December 13, 2019
Smart Business Dealmakers Pittsburgh: UPMC Enterprises Invests In Werewolf Therapeutics
UPMC Enterprises joined a Series A funding round of $56 million for Werewolf Therapeutics. The Cambridge, Massachusetts-based oncology biotherapeutics company is developing novel immuno-stimulatory therapeutics designed to act selectively within the tumor microenvironment to enhance the body’s immune response to cancer.
Smart Business Dealmakers Pittsburgh
By Jayne Gest